Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently
reported that clinical lab tests conducted with live animals demonstrated that
its new, enhanced version of DehydraTECH(TM) can deliver eight times more
CBD into the blood and 19 times more CBD into the brain tissue than standard
industry formulations (http://ibn.fm/5y9TR).
An article discussing the company reads, “LXRP intends to perform more studies
on the enhanced DehydraTECH and focus on optimizing implementation regarding
product applications for its licensees. . . . In earlier test results, LXRP
announced that original or standard DehydraTECH combined with generic nanotech
techniques delivers 1,137% more cannabidiol (CBD) into animal brain tissue
following oral ingestion than certain existing industry formulations (http://ibn.fm/kxoTG). The tests
consisted of oral administration of CBD into 10 male Sprague-Dawley rats.”
To view the full article, visit http://ibn.fm/H805n
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive, patented-delivery
technology that promotes healthier ingestion methods, lower overall dosing and
higher effectiveness of lipophilic active molecules. Lexaria has multiple
patents pending in over 40 countries around the world and has patents granted
in the United States and Australia for utilization of its DehydraTECH delivery
technology. Lexaria’s technology provides increases in intestinal absorption
rates, more rapid delivery to the bloodstream, and important taste-masking
benefits for orally administered bioactive molecules including cannabinoids,
vitamins, nonsteroidal anti-inflammatory drugs (NSAIDs), nicotine and other
molecules. For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates
relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment